Generic Drugs in the Era of Artificial Intelligence: Bridging Cost, Quality, and Technology in Modern Pharmacotherapy | ||
| Egyptian Journal of Health Sciences Technology | ||
| Articles in Press, Accepted Manuscript, Available Online from 11 August 2025 | ||
| Document Type: Original Article | ||
| DOI: 10.21608/ejhst.2025.399621.1003 | ||
| Authors | ||
| Alyaa Elrashedy* 1; Rokaya Samy2; Eman Essam2; Abdullah Samy2; Tasneem Salim2; Ahmed Maher2; Abdelrahman Ahmed2; Mohamed E. Hasan3; saeed Awad2 | ||
| 1Department of Animal Medicine and Infectious Diseases, Faculty of Veterinary Medicine, University of Sadat City, Egypt. Faculty of Applied Health Science, Borg Al Arab Technological University (BATU), Alexandria, Egypt | ||
| 2Faculty of Applied Health Science, Borg Al Arab Technological University (BATU), Alexandria, Egypt | ||
| 3Faculty of Applied Health Science, Borg Al Arab Technological University (BATU), Alexandria, Egypt Bioinformatics Department, Genetic Engineering and Biotechnology Research Institute, University of Sadat City, Egypt. | ||
| Abstract | ||
| Generic medications have become fundamental in addressing rising healthcare costs while maintaining patient safety and treatment efficacy. This detailed analysis explores the regulatory frameworks, scientific standards, and economic implications surrounding the practice of generic substitution. Particular emphasis is placed on the importance of pharmaceutical and bioequivalence standards, which ensure that generics match brand-name drugs in quality, safety, and performance. Furthermore, the paper highlights how cutting-edge technologies, especially bioinformatics and artificial intelligence, are transforming pharmaceutical research. These tools accelerate drug discovery, optimize clinical trial design, and support the development of both branded and generic medicines. The analysis also considers global trends, including the public’s perception of generic drugs and the role of government and industry in shaping acceptance. Ultimately, the discussion underscores the urgent need for transparent regulatory policies and educational campaigns to build trust and awareness. These efforts are vital to maximizing the impact of generic drugs as accessible, effective, and sustainable healthcare solutions worldwide. | ||
| Keywords | ||
| Bioinformatics; Drug Design; Drug Discovery; Generic drug; Healthcare | ||
|
Statistics Article View: 99 |
||
